BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33601099)

  • 1. Generation and characterization of an integration-free iPSC line SDUBMSi006-A from a patient with Alport syndrome caused by COL4A3 gene mutations.
    Ma Y; Wang Z; Liu X; Sun W; Gong Y; Liu G; Sun G
    Stem Cell Res; 2021 Apr; 52():102237. PubMed ID: 33601099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carrying a homozygous mutation in COL4A3 gene.
    Wu H; Wang G; Gao E; Zhang L; Zhu Y; Zhang J; Liu Z
    Stem Cell Res; 2021 Oct; 56():102557. PubMed ID: 34626894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of the induced pluripotent stem cell line (NCKDi005-A) from a male patient with Alport syndrome carrying a homozygous frameshift mutation in the COL4A4 gene.
    Wang G; Gao E; Wu H; Zhang L; Zhu Y; Zhang J; Liu Z
    Stem Cell Res; 2022 Jan; 58():102628. PubMed ID: 34942480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
    Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
    Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound Mutations of the COL4A3 including a Novel Allele Identified in a Patient with Alport Syndrome.
    Wang Z; Jiang B; Jin S; Hu Z; Liu G
    Biomed Res Int; 2020; 2020():1626378. PubMed ID: 33524082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
    Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.
    Liu JH; Wei XX; Li A; Cui YX; Xia XY; Qin WS; Zhang MC; Gao EZ; Sun J; Gao CL; Liu FX; Wu QY; Li WW; Asan ; Liu ZH; Li XJ
    PLoS One; 2017; 12(5):e0177685. PubMed ID: 28542346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.
    Sun L; Zhang J; Kuang XY; Kang YL; Wu Y; Huang WY
    Stem Cell Res; 2020 May; 45():101833. PubMed ID: 32416580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique.
    Zhao X; Chen C; Wei Y; Zhao G; Liu L; Wang C; Zhang J; Kong X
    Mol Genet Genomic Med; 2019 Jun; 7(6):e653. PubMed ID: 30968591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.
    Ma Y; Wang Z; Gao M; Liu X; Sun W; Gong Y; Sun G; Liu G
    Stem Cell Res; 2021 May; 53():102343. PubMed ID: 33878711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.
    Hirayama R; Toyohara K; Watanabe K; Otsuki T; Araoka T; Mae SI; Horinouchi T; Yamamura T; Okita K; Hotta A; Iijima K; Nozu K; Osafune K
    Commun Biol; 2023 Sep; 6(1):854. PubMed ID: 37770589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
    Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
    Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
    Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
    BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
    Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family.
    Guo L; Li D; Dong S; Wan D; Yang B; Huang Y
    J Genet; 2017 Jun; 96(2):389-392. PubMed ID: 28674241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study.
    Uliana V; Sebastio P; Riva M; Carli D; Ruberto C; Bianchi L; Graziano C; Capelli I; Faletra F; Pillon R; Mattina T; Sensi A; Bonatti F; Percesepe A
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1576. PubMed ID: 33369211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.
    Slajpah M; Gorinsek B; Berginc G; Vizjak A; Ferluga D; Hvala A; Meglic A; Jaksa I; Furlan P; Gregoric A; Kaplan-Pavlovcic S; Ravnik-Glavac M; Glavac D
    Kidney Int; 2007 Jun; 71(12):1287-95. PubMed ID: 17396119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.